PATRIARCA, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 649
NA - Nord America 413
AS - Asia 129
OC - Oceania 4
AF - Africa 1
Totale 1.196
Nazione #
US - Stati Uniti d'America 405
IE - Irlanda 259
IT - Italia 179
SE - Svezia 113
DE - Germania 53
HK - Hong Kong 52
SG - Singapore 38
UA - Ucraina 21
IN - India 15
FR - Francia 13
CA - Canada 8
VN - Vietnam 8
IR - Iran 7
FI - Finlandia 6
AU - Australia 4
CN - Cina 4
TR - Turchia 3
CZ - Repubblica Ceca 2
RU - Federazione Russa 2
SY - Repubblica araba siriana 2
DK - Danimarca 1
NG - Nigeria 1
Totale 1.196
Città #
Dublin 252
Piemonte 70
Chandler 66
Hong Kong 52
Jacksonville 33
Lawrence 25
Princeton 25
Boardman 21
Bremen 21
Singapore 20
San Mateo 16
Grafing 13
Wilmington 13
Novara 10
Strasbourg 10
Dong Ket 8
Toronto 8
Andover 7
Turin 7
Ashburn 6
Helsinki 6
Beijing 4
Houston 4
Sydney 4
West Jordan 4
Berlin 3
Leawood 3
Mülheim 3
Norwalk 3
Ann Arbor 2
Augusta 2
Brno 2
Cambridge 2
Castellazzo Bormida 2
Cornedo Vicentino 2
Fairfield 2
Foligno 2
Kocaeli 2
Legnano 2
Milan 2
Opera 2
Perugia 2
Redwood City 2
Sacramento 2
Saint-Fons 2
Venice 2
Vercelli 2
Zanjan 2
Ankara 1
Bari 1
Cassano Magnago 1
Chieti 1
Dallas 1
Duncan 1
Gatchina 1
Genoa 1
Magreglio 1
Monmouth Junction 1
Odalengo Grande 1
Pune 1
Saint Paul 1
Sanremo 1
Santa Maria a Vico 1
St Petersburg 1
Trani 1
Vailate 1
Verona 1
Vigliano Biellese 1
Villavesco 1
Woodbridge 1
Totale 777
Nome #
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 105
Targeting p53 in chronic lymphocytic leukemia 62
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 59
An update on: molecular genetics of high-risk chronic lymphocytic leukemia 56
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 55
Genetic predisposition to myelodysplastic syndromes: A challenge for adult hematologists 54
Precision medicine management of chronic lymphocytic leukemia 49
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 49
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: The OnCovid Inflammatory Score 45
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms 45
Precision Medicine in Systemic Mastocytosis 44
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study 43
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 43
Ponatinib for the treatment of Ph-like acute lymphoblastic leukemia 42
An acquired factor V inhibitor induced uncontrolled bleeding in a postsurgery patient 42
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma 40
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL 39
Atypical chronic myeloid leukemia: Where are we now? 39
High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module 37
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients 37
A step ahead toward precision medicine for chronic lymphocytic leukemia 30
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study 28
Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients 28
Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemia 27
The Biology of Chronic Lymphocytic Leukemia: Diagnostic and Prognostic Implications 27
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study 24
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients 22
Intravascular lymphoma: from vessels to genes 20
Investigational drugs for the treatment of diffuse large B-cell lymphoma 18
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry 11
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer 9
High BECN1 Expression Negatively Correlates with BCL2 Expression and Predicts Better Prognosis in Diffuse Large B-Cell Lymphoma: Role of Autophagy 8
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries 7
Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies 5
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry 4
Totale 1.253
Categoria #
all - tutte 7.568
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.568


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202035 0 0 0 0 0 0 4 2 3 21 4 1
2020/2021126 10 2 5 0 13 8 13 0 19 21 24 11
2021/2022274 7 4 21 34 18 10 23 13 13 36 50 45
2022/2023543 46 22 47 4 35 47 25 20 250 3 25 19
2023/2024269 27 23 23 7 38 9 36 6 4 5 37 54
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 1.253